Monday, 13 July 2020

Itolizumab receives DCGI nod for moderate to severe COVID-19



source https://www.pharmatutor.org/pharma-news/2020/itolizumab-receives-dcgi-nod-for-moderate-to-severe-covid-19
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Pharmaceutical jobs for MPharm / MSc / BPharm or BSc - DPharm or PharmD and PhD

  Openings for Pharmacists under the National Health Mission Degree or Diploma in Pharmacy (50%) & Registration in CG Pharmacy Registrat...